Prospective Investigation of Multiple Sclerosis in the Three Rivers Region

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

In this longitudinal prospective natural history study of multiple sclerosis (MS), the overarching goal is to understand the factors that influence individual variation in disease trajectory and treatment response and pave the way for realizing precision medicine in MS. Because MS is a chronic neurological disorder, this observational cohort study will span a 30-year time frame.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 7
Healthy Volunteers: t
View:

• Inclusion criteria for MS patients include:

‣ willing and able to give consent

⁃ age 7 years or older

⁃ diagnosis of multiple sclerosis or related disorders, including a first central nervous system demyelinating episode with a positive MRI scan or abnormal MRI scans characteristic of MS but no clinical symptoms of the disease

• For healthy controls:

‣ Age 7 years or older

⁃ Willing and able to provide consent (for \>=18 years) or assent with permission from at least one of the child's parents (for \<18 years)

⁃ No known personal history of multiple sclerosis or related disorders

⁃ No other chronic diseases

⁃ Family members, unrelated household controls, or controls from the general population could be eligible

Locations
United States
Pennsylvania
University of Pittsburgh
RECRUITING
Pittsburgh
Contact Information
Primary
Zongqi Xia, MD, PhD
msstudy2@pitt.edu
412-383-5377
Time Frame
Start Date: 2016-12
Estimated Completion Date: 2047-01
Participants
Target number of participants: 7500
Treatments
People with Multiple Sclerosis or Related Disorders
Individuals must be 7 years or older, diagnosed with multiple sclerosis or related disorders, including a first central nervous system demyelinating episode with a positive MRI scan or abnormal MRI scans characteristic of MS but no clinical symptoms of the disease
People without Multiple Sclerosis or Related Disorders
Control participants must be 7 years or older, have no known personal history of multiple sclerosis or related disorders, no other chronic disease, and can be a family member, unrelated household control, or control from the general population.
Related Therapeutic Areas
Sponsors
Leads: University of Pittsburgh

This content was sourced from clinicaltrials.gov